Pharmacoepidemiology and “in silico” drug evaluation: is there common ground?
نویسندگان
چکیده
منابع مشابه
Database Access Control and Privacy: Is there a common ground?
Data privacy issues are increasingly becoming important for many applications. Traditionally, research in the database community in the area of data security can be broadly classified into access control research and data privacy research. Surprisingly, there is little overlap between these two areas. In this paper, we open up a discussion that asks if there is a suitable middle-ground between ...
متن کاملDatabase Access Control & Privacy: Is There A Common Ground?
Data privacy issues are increasingly becoming important for many applications. Traditionally, research in the database community in the area of data security can be broadly classified into access control research and data privacy research. Surprisingly, there is little overlap between these two areas. In this paper, we open up a discussion that asks if there is a suitable middle-ground between ...
متن کاملAdvances in Pharmacoepidemiology & Drug Safety
This article was originally published in a journal by OMICS Publishing Group, and the attached copy is provided by OMICS Publishing Group for the author’s benefit and for the benefit of the author’s institution, for commercial/research/educational use including without limitation use in instruction at your institution, sending it to specific colleagues that you know, and providing a copy to you...
متن کاملEthics and the law: is there common ground on informed consent for disparities in hospital outcomes?
The association between procedure volume at institutions and outcomes of cancer surgeries has been widely published in the medical literature; discussed in the lay press; and, during the past 15 years, incorporated into quality improvement endeavors. In certain cases, institutional volume has become a proxy for quality. Despite the vast amount of retrospective data on this topic, physicians gen...
متن کاملIn silico prediction of drug safety: despite progress there is abundant room for improvement.
Predictive models for drug safety are crucial for helping to avoid costly late-stage failures. We review recent work on models for genotoxicity, liver toxicity, CYP450 inhibition and cardiotoxicity. These models have improved somewhat in recent years, and research has expanded into new frontiers, such as the prediction of liver toxicity. However, much more needs to be done.:
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Epidemiology
سال: 2008
ISSN: 0895-4356
DOI: 10.1016/j.jclinepi.2007.07.006